SF HAL 25/250MCG INHALER

SF HAL 25/250MCG INHALER is a combination respiratory medication containing salmeterol and fluticasone propionate. This dual-action inhaler delivers a long-acting beta-2 agonist (salmeterol) for bronchodilation and an inhaled corticosteroid (fluticasone propionate) for anti-inflammatory benefits. Designed for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), this inhaler helps improve airflow, reduce airway inflammation, and provide sustained symptom relief throughout the day. The 25/250 microgram dosage combines effective bronchial relaxation with controlled inflammation management. Suitable for patients requiring regular preventive therapy, SF HAL offers convenient twice-daily dosing to help maintain respiratory function and reduce exacerbation frequency. Always use as directed by your healthcare provider.